The Agence nationale de sécurité du médicament et des produits de santé publishes on its website :
1° The initial compassionate prescribing framework, the protocol for therapeutic use and patient follow-up and any amendments, indicating the date on which they come into force and the date on which they cease to have effect;
2° Summaries of the periodic summary reports approved by the Director General of the Agency;
3° The list of medicinal products for which a compassionate prescription framework has not been established following a report from one of the organisations mentioned in 1° to 4° of article R. 5121-76-2, in a given therapeutic indication.
The list of medicinal products covered by a compassionate prescribing framework and those for which this prescribing framework has ceased to be effective is published on the website of the Ministry of Health.